BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,122,847,000 | +46.5% | 2,368,000 | +20.2% | 0.01% | +50.0% |
Q4 2019 | $2,131,205,000 | +7.0% | 1,970,000 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $1,991,311,000 | -49.7% | 1,941,000 | -45.0% | 0.00% | -50.0% |
Q2 2019 | $3,962,763,000 | -0.4% | 3,532,000 | +0.6% | 0.01% | -11.1% |
Q1 2019 | $3,980,094,000 | +628.7% | 3,510,000 | +619.3% | 0.01% | +800.0% |
Q4 2018 | $546,209,000 | -99.3% | 488,000 | -33.6% | 0.00% | -98.6% |
Q3 2014 | $80,482,496,000 | -74.5% | 735,000 | -75.5% | 0.07% | -76.4% |
Q2 2014 | $315,929,984,000 | – | 3,000,000 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |